Virax Biolabs Group LtdNASDAQ:VRAX
- LAST PRICE1.9400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.8400/ 1
- Ask / Lots2.0000/ 1
- Open / Previous Close--- / 1.9400
- Day Range---
- 52 Week Range
- Volume2,640
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VRAX |
|---|---|---|
| 09:32 ET | 731 | 1.868 |
| 09:33 ET | 476 | 1.85 |
| 09:35 ET | 2229 | 1.88 |
| 09:37 ET | 1700 | 1.84 |
| 09:39 ET | 3000 | 1.8401 |
| 09:46 ET | 300 | 1.85 |
| 09:48 ET | 1000 | 1.8401 |
| 09:51 ET | 240 | 1.8405 |
| 09:57 ET | 2058 | 1.84 |
| 10:00 ET | 255 | 1.85 |
| 10:04 ET | 240 | 1.8401 |
| 10:13 ET | 1200 | 1.84 |
| 10:26 ET | 200 | 1.83 |
| 10:29 ET | 1501 | 1.83 |
| 10:31 ET | 119 | 1.83 |
| 10:33 ET | 3000 | 1.82 |
| 10:40 ET | 120 | 1.83 |
| 10:47 ET | 4000 | 1.83 |
| 10:49 ET | 100 | 1.83 |
| 11:14 ET | 242 | 1.8374 |
| 11:16 ET | 1731 | 1.83 |
| 11:25 ET | 1100 | 1.831 |
| 11:30 ET | 100 | 1.83 |
| 11:32 ET | 1320 | 1.83 |
| 11:52 ET | 232 | 1.83 |
| 11:59 ET | 1300 | 1.845 |
| 12:33 ET | 1100 | 1.84 |
| 12:39 ET | 994 | 1.8599 |
| 12:50 ET | 3000 | 1.86 |
| 12:57 ET | 7055 | 1.9174 |
| 01:02 ET | 206 | 1.9034 |
| 01:04 ET | 6700 | 1.89 |
| 01:33 ET | 400 | 1.8777 |
| 01:40 ET | 100 | 1.87 |
| 01:42 ET | 114 | 1.88 |
| 01:51 ET | 6673 | 1.91 |
| 01:54 ET | 10000 | 1.93 |
| 01:58 ET | 500 | 1.92 |
| 02:14 ET | 100 | 1.9101 |
| 02:36 ET | 3835 | 1.885 |
| 02:45 ET | 100 | 1.92 |
| 03:01 ET | 6871 | 1.94 |
| 03:17 ET | 125 | 1.9606 |
| 03:19 ET | 500 | 1.96 |
| 03:26 ET | 700 | 1.96 |
| 03:33 ET | 200 | 1.955 |
| 03:46 ET | 8450 | 1.94 |
| 03:48 ET | 500 | 1.93 |
| 03:50 ET | 2800 | 1.95 |
| 03:51 ET | 701 | 1.94 |
| 04:00 ET | 3637 | 1.94 |
Oct 23, 2024
DJ Virax Biolabs Shares Rise Sharply on Distribution Agreement, from 2:18PM ET on Wednesday Oct 23, 2024 by Dow Jones
2:18PM ET on Wednesday Oct 23, 2024 by Dow JonesVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland, from 7:30AM ET on Wednesday Oct 23, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Virax Biolabs Group Ltd | 7.9M | -0.6x | --- |
Evaxion Biotech A/S | 7.6M | -0.1x | --- |
ABVC Biopharma Inc | 7.1M | -0.6x | --- |
Mustang Bio Inc | 7.7M | -0.1x | --- |
Moleculin Biotech Inc | 8.1M | -0.2x | --- |
Curative Biotechnology Inc | 7.8M | -0.8x | --- |
Company Information
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Contact Information
- Headquarters
- Biocity Glasgow, Bo'ness Road, NewhouseLONDON, United Kingdom ML1 5UH
- Phone
- 207-788-7414
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- James Foster
- Chief Financial Officer
- Jason Davis
- Chief Operating Officer, Director
- Nigel Mccracken
- Independent Director
- Yair Erez
- Independent Director
- Nelson Haight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.9M |
|---|---|
Revenue (TTM) | $156.4K |
Shares Outstanding | 4.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.35 |
Book Value | $2.09 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 50.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,153.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
